India to Philippines: Telmisartan Export Trade Route
India has recorded 448 verified shipments of Telmisartan exported to Philippines, representing a combined trade value of $10.1M USD. This corridor is served by 53 active Indian exporters, with an average shipment value of $22.5K USD. The leading Indian exporter is MEDIWIN PHARMACEUTICALS, which accounts for 50% of total export value with 18 shipments worth $5.1M USD. On the buying side, EUROASIA PHARMACEUTICALS INC is the largest importer in Philippines with $5.0M USD in purchases. The top 3 suppliers — MEDIWIN PHARMACEUTICALS, INTAS PHARMACEUTICALS LIMITED, TITAN LABORATORIES PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Telmisartan corridor is one of India's established pharmaceutical export routes, with 448 shipments documented worth a combined $10.1M USD. The route is dominated by MEDIWIN PHARMACEUTICALS, which alone accounts for roughly 50% of all export value, reflecting the consolidated nature of India's telmisartan manufacturing sector.
Across 53 active suppliers, the average shipment value stands at $22.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with telmisartan's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 23.3%, placing it at rank #9 among India's top telmisartan export destinations globally.
On the import side, key buyers of Indian telmisartan in Philippines include EUROASIA PHARMACEUTICALS INC, NELPA LIFESCIENCES INC, A I C and 73 others. EUROASIA PHARMACEUTICALS INC is the single largest importer with 17 shipments valued at $5.0M USD.
Route Characteristics
- Average transit
